SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    William T. Berg, Matthew R. Danzig, Jamie S. Pak, Ruslan Korets, Arindam RoyChoudhury, Gregory Hruby, Mitchell C. Benson, James M. McKiernan, Ketan K. Badani, Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes, The Prostate, 2015, 75, 10
  2. 2
    Manigreeva Krishnatreya, Amal Chandra Kataki, Jagannath Dev Sharma, Pintu Nandy, Tashnin Rahman, Mahesh Kumar, Gayatri Gogoi, Nazmul Hoque, Educational Levels and Delays in Start of Treatment for Head and Neck Cancers in North-East India, Asian Pacific Journal of Cancer Prevention, 2015, 15, 24, 10867

    CrossRef

  3. 3
    R Nash, J Hughes, A Sandison, S Stewart, P Clarke, A Mace, Factors associated with delays in head and neck cancer treatment: case–control study, The Journal of Laryngology & Otology, 2015, 129, 04, 383

    CrossRef

  4. 4
    French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer, European Annals of Otorhinolaryngology, Head and Neck Diseases, 2015,

    CrossRef

  5. 5
    Jonghun John Lee, Chris Dhepnorrarat, Joyce Nyhof-Young, Ian Witterick, Investigating Patient and Physician Delays in the Diagnosis of Head and Neck Cancers: a Canadian Perspective, Journal of Cancer Education, 2015,

    CrossRef

  6. 6
    Han Zhang, Peter T. Dziegielewski, T.T. Jean Nguyen, Caroline C. Jeffery, Daniel A. O’Connell, Jeffrey R. Harris, Hadi Seikaly, The effects of geography on survival in patients with oral cavity squamous cell carcinoma, Oral Oncology, 2015, 51, 6, 578

    CrossRef

  7. 7
    Rebecca Bütof, Michael Baumann, Time in radiation oncology – Keep it short!, Radiotherapy and Oncology, 2013, 106, 3, 271

    CrossRef

  8. 8
    Katrin Oertel, Karin Spiegel, Harald Schmalenberg, Andreas Dietz, Georg Maschmeyer, Thomas Kuhnt, Holger Sudhoff, Thomas G Wendt, Orlando Guntinas-Lichius, Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1), BMC Cancer, 2012, 12, 1, 483

    CrossRef